U.S. Biosimilar Contract Manufacturing Market Size & Outlook

Name: U.S. Biosimilar Contract Manufacturing Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The biosimilar contract manufacturing market in the United States is expected to reach a projected revenue of US$ 6,769.9 million by 2033. A compound annual growth rate of 14.2% is expected of the United States biosimilar contract manufacturing market from 2025 to 2033.

U.S. biosimilar contract manufacturing product outlook (Revenue, USD million, 2021-2033)
- Recombinant Non-Glycosylated Proteins
- Recombinant Glycosylated Proteins
U.S. biosimilar contract manufacturing production technology outlook (Revenue, USD million, 2021-2033)
- Mammalian
- Non-Mammalian
U.S. biosimilar contract manufacturing application outlook (Revenue, USD million, 2021-2033)
- Oncology
- Blood Disorders
- Growth Hormonal Deficiency
- Rheumatoid Arthritis
- Chronic and Autoimmune Disorders
- Others

U.S. Biosimilar Contract Manufacturing Market Size & Outlook

Sign up - it's easy, and free!